Published in African Health Sciences, June 2009, by Vinod Mishra of ICF Macro; Josephine Bwogi, and Barnabas Bakamutumaho, and Benon Biryahwaho of Uganda Virus Research Institute; Fiona Braka, Miriam Nanyunja, and Rosamund F. Lewis of the World Health Organization; Issa Makumbi and Alex Opio of the Uganda Ministry of Health; and Robert Downing of the Centers for Disease Control and Prevention/Uganda. The study was carried out to determine the baseline prevalence of hepatitis B virus (HBV) infection and explore its risk factors. Results indicated that hepatitis B virus infection is highly endemic in Uganda, with an estimated 1.4 million adults chronically infected and some communities disproportionately affected. The study highlighted the need to strengthen the hepatitis B infant immunization program and to promote HBV testing and vaccination among HIV-infected persons.
Related Market + Service Offerings